GTC Biotherapeutics (fka GTCB)

[croumagnon]

Sorry, I forgot about that earlier post. However, if you quote the full sentence instead of parsing it, you will see that I did not plan on selling below $0.9, namely:

"Below $0.9, selling GTCB currently does not make sense because they have other blockbusters in their pipeline besides ATryn and I presume the chance of good top line data is better than 50/50 although the selling lately is worrisome"

At any rate, as I clarified in following posts, I only sold 26,000 shares a couple of days ago at $0.92 and I bought them back plus some today at $0.89...

I am still worried but I think this is a steal below $0.9...